Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2010

Authors

  • Deepika Mahajan National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Rob Menzies National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Jane Cook Office of Product Review, Therapeutic Goods Administration, Canberra, New South Wales
  • Kristine Macartney National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales
  • Peter McIntyre National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases, University of Sydney and The Children’s Hospital at Westmead, Sydney, New South Wales

DOI:

https://doi.org/10.33321/cdi.2011.35.5

Keywords:

immunisation, AEFI, childhood immunisation

Abstract

Ongoing surveillance of adverse events following immunisation, and regular analysis and reporting of these data, are integral to the management of immunisation programs. An 'adverse event following immunisation' is defined as any serious or unexpected adverse event that occurs after a vaccination has been given which may be related to the vaccine itself or to its handling or administration. An AEFI can be coincidentally associated with the timing of immunisation without necessarily being caused by the vaccine or the immunisation process. This report covers the period 1 January to 30 June 2010.

Downloads

Download data is not yet available.

References

National Health and Medical Research Council. The Australian Immunisation Handbook. 9th edn. Canberra: Australian Government Department of Health and Ageing, 2008.

Victorian State Government, Department of Health. National Immunisation Program Schedule. [online] Accessed on 1 December 2010. Available from: http://health.vic.gov.au/immunisation/fact-sheets/factsheets/schedule_victoria

Australian Government Department of Health and Ageing, Therapeutic Goods Administration. TGA approves vaccine against pandemic (H1N1) 2009 influenza. Media release 18 September 2009. Accessed on 2 December 2010. Available from: http://www.tga.gov.au/archive/media-2006.htm

Government of South Australia Department of Health. New vaccine schedule from 1st March 2008. Sharp and to the point 2008;(23):1. [serial online]. Accessed on 30 August 2010. Available from: http://www.dh.sa.gov.au/pehs/Immunisation/0803-sharp-point-news.pdf

Queensland Health. National Immunisation Program Queensland schedule. [online] Accessed on 1 September 2010. Available from: http://www.health.sa.gov.au/immunisationcalculator/QldMar2008.pdf

Victorian Department of Human Services. Changed immunisation schedule from 1 March 2008. Immunisation newsletter 2008;(32):1. [serial online]. Accessed on 1 September 2010. Available from: http://www.health.vic.gov.au/__data/assets/pdf_file/0015/130083/Immunisation-newsletter-issue-32.pdf

Centers for Disease Control and Prevention. Continued shortage of Haemophilus influenzae type b (Hib) conjugate vaccines and potential implications for Hib surveillance—United States, 2008. MMWR Morb Mortal Wkly Rep 2008;57(46):1252–1255.

Australian Government Department of Health and Ageing. Media release 23 April 2010: Seasonal Flu Vaccine and young children. [online] Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/mr-yr10-dept-dept230410.htm

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, et al. Surveillance of adverse events following immunisation: Australia, 2000–2002. Commun Dis Intell 2003;27(3):307–323.

Mahajan D, Menzies R, Roomiani I, Lawrence GL. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2009. Commun Dis Intell 2010;34(1):49–53.

Mahajan D, Roomiani I, Gold M, Lawrence G, McIntyre P, Menzies R. Annual report: surveillance of adverse events following immunisation in Australia, 2009. Commun Dis Intell 2010;34(3):259–276.

Menzies R, Mahajan D, Gold MS, Roomiani I, McIntyre P, Lawrence G. Annual report: surveillance of adverse events following immunisation in Australia, 2008. Commun Dis Intell 2009;33(4):365–381.

Australian Institute of Health and Welfare. 2010 Pandemic Vaccination Survey: summary results. Cat. No. PHE 128. Canberra: Australian Institute of Health and Welfare, 2010. [online] Accessed on 1 December 2010. Available from: http://www.aihw.gov.au/publications/phe/128/12096.pdf

Lawrence GL, Mahajan D, Roomiani I. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2008. Commun Dis Intell 2009;33(1):27–31.

Government of Western Australia, Department of Health. WA vaccination schedule. [online] Accessed on 1 December 2010. Available from: http://www.public.health.wa.gov.au/3/470/3/schedule__immunisation.pm

Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Investigation into febrile reactions in young children following 2010 seasonal trivalent influenza vaccination. Status report as at 2 July 2010. [online] Available from: http://www.tga.gov.au/safety/alerts-medicine-seasonal-flu-100702.htm

Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Overview of vaccine regulation and safety monitoring and investigation into adverse events following 2010 seasonal influenza vaccination in young children. 8 October 2010. [online] Available from: http://www.tga.gov.au/safety/alerts-medicine-seasonal-flu-101008.htm

Australian Government Department of Health and Ageing, Therapeutic Goods Administration, Cook J. Australian experience with non-adjuvant H1N1 vaccine (Panvax and Panvax Junior). Medicines Safety Update No. 4, 2010. Accessed on 30 August 2010. Available from: http://www.tga.gov.au/hp/msu-2010-04.htm

World Health Organization. Safety of pandemic A(H1N1) influenza vaccines. Wkly Epidemiol Record 2010;85(5):29–36.

Nolan T, McVernon J, Skeljo M, Richmond P, Wadia U, Lambert S. Immunogenicity of a monovalent 2009 influenza A(H1N1) vaccine in infants and children: a randomized trial. JAMA 2010;303(1):37–46.

Australian Government Department of Health and Ageing, Therapeutic Goods Administration. Suspected adverse reactions to Panvax® reported to the TGA 30 September 2009 to 17 September 2010. Advisory 6 October 2010. [online] Available from:http://www.tga.gov.au/safety/alerts-medicine-pandemic-influenza-090918.htm

Australian Government Department of Health and Ageing. Media release 30 July 2010: Seasonal flu vaccination for young children can be resumed – Updated advice from the Chief Medical Officer. [online] Available from: http://www1.health.gov.au/internet/main/publishing.nsf/Content/mr-yr10-dept-dept300710.htm

Downloads

Published

01/03/11

How to Cite

Mahajan, Deepika, Rob Menzies, Jane Cook, Kristine Macartney, and Peter McIntyre. 2011. “Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged Less Than 7 Years in Australia, 1 January to 30 June 2010”. Communicable Diseases Intelligence 35 (March):21-28. https://doi.org/10.33321/cdi.2011.35.5.

Issue

Vol. 35 (2011)

Section

Surveillance summary

Categories

License

Copyright (c) 2011 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)

1 2 3 4 5 6 7 8 9 > >>